ABEONA THERAPEUTICS INC. Diluted Shares Outstanding (Weighted Average)
ABEONA THERAPEUTICS INC. (ABEO) reported Diluted Shares Outstanding (Weighted Average) of 57.05 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding · last filed 2026-08-13
- ABEONA THERAPEUTICS INC. weighted average number of shares outstanding, diluted for the quarter ending 2026-06-30 was 57.05M shares, a 14.39% decline year-over-year.
- ABEONA THERAPEUTICS INC. weighted average number of shares outstanding, diluted for the quarter ending 2026-03-31 was 56.62M shares, a 13.75% increase year-over-year.
- ABEONA THERAPEUTICS INC. weighted average number of shares outstanding, diluted for the quarter ending 2025-12-31 was 67.20M shares, a 38.05% increase year-over-year.
- ABEONA THERAPEUTICS INC. weighted average number of shares outstanding, diluted for the quarter ending 2025-09-30 was 54.24M shares, a 12.81% increase year-over-year.
- ABEONA THERAPEUTICS INC. weighted average number of shares outstanding, diluted for fiscal 2025 was 66.14M shares, a 61.12% increase from fiscal 2024.
- ABEONA THERAPEUTICS INC. weighted average number of shares outstanding, diluted for fiscal 2024 was 41.05M shares, a 91.99% increase from fiscal 2023.
- ABEONA THERAPEUTICS INC. weighted average number of shares outstanding, diluted for fiscal 2023 was 21.38M shares, a 171.96% increase from fiscal 2022.
- ABEONA THERAPEUTICS INC. weighted average number of shares outstanding, diluted for fiscal 2022 was 7.86M shares.
| Period end | Weighted Average Number of Shares Outstanding, Diluted 3 month | Weighted Average Number of Shares Outstanding, Diluted 3 month as first filed | Weighted Average Number of Shares Outstanding, Diluted 6 month | Weighted Average Number of Shares Outstanding, Diluted 9 month | Weighted Average Number of Shares Outstanding, Diluted 9 month as first filed | Weighted Average Number of Shares Outstanding, Diluted 12 month | Weighted Average Number of Shares Outstanding, Diluted 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | 57.05M shares 10-Q · filed 2026-08-13 | 56.84M shares 10-Q · filed 2026-08-13 | 60.29M shares derived: average of 3 quarters · filed 2026-08-13 | 58.78M shares derived: average of 4 quarters · filed 2026-08-13 | |||
| 2026-03-31 | 56.62M shares 10-Q · filed 2026-05-13 | 61.91M shares derived: average of 2 quarters · filed 2026-05-13 | 59.35M shares derived: average of 3 quarters · filed 2026-05-13 | 61.18M shares derived: average of 4 quarters · filed 2026-08-13 | |||
| 2025-12-31 | 67.20M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-17 | 60.72M shares derived: average of 2 quarters · filed 2026-03-17 | 62.69M shares derived: average of 3 quarters · filed 2026-08-13 | 66.14M shares 10-K · filed 2026-03-17 | |||
| 2025-09-30 | 54.24M shares 10-Q · filed 2025-11-12 | 60.44M shares derived: average of 2 quarters · filed 2026-08-13 | 65.78M shares 10-Q · filed 2025-11-12 | 54.84M shares derived: average of 4 quarters · filed 2026-08-13 | |||
| 2025-06-30 | 66.64M shares 10-Q · filed 2026-08-13 | 65.11M shares 10-Q · filed 2026-08-13 | 55.03M shares derived: average of 3 quarters · filed 2026-08-13 | 53.30M shares derived: average of 4 quarters · filed 2026-08-13 | |||
| 2025-03-31 | 49.78M shares 10-Q · filed 2026-05-13 | 49.23M shares derived: average of 2 quarters · filed 2026-05-13 | 48.85M shares derived: average of 3 quarters · filed 2026-05-13 | 49.44M shares derived: average of 4 quarters · filed 2026-05-13 | |||
| 2024-12-31 | 48.68M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-17 | 48.38M shares derived: average of 2 quarters · filed 2026-03-17 | 49.33M shares derived: average of 3 quarters · filed 2026-03-17 | 41.05M shares 10-K · filed 2026-03-17 | |||
| 2024-09-30 | 48.08M shares 10-Q · filed 2025-11-12 | 49.65M shares derived: average of 2 quarters · filed 2025-11-12 | 38.50M shares 10-Q · filed 2025-11-12 | 38.08M shares derived: average of 4 quarters · filed 2025-11-12 | |||
| 2024-06-30 | 51.23M shares 10-Q · filed 2025-08-14 | 33.66M shares 10-Q · filed 2025-08-14 | 34.75M shares derived: average of 3 quarters · filed 2025-08-14 | 32.26M shares derived: average of 4 quarters · filed 2025-08-14 | |||
| 2024-03-31 | 27.32M shares 10-Q · filed 2025-05-15 | 26.50M shares derived: average of 2 quarters · filed 2025-05-15 | 25.94M shares derived: average of 3 quarters · filed 2025-05-15 | 23.96M shares derived: average of 4 quarters · filed 2025-05-15 | |||
| 2023-12-31 | 25.69M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | 25.25M shares derived: average of 2 quarters · filed 2025-03-20 | 22.84M shares derived: average of 3 quarters · filed 2025-03-20 | 21.38M shares 10-K · filed 2025-03-20 | |||
| 2023-09-30 | 24.80M shares 10-Q · filed 2024-11-14 | 21.41M shares derived: average of 2 quarters · filed 2024-11-14 | 19.94M shares 10-Q · filed 2024-11-14 | 18.28M shares derived: average of 4 quarters · filed 2024-11-14 | |||
| 2023-06-30 | 18.02M shares 10-Q · filed 2024-08-12 | 17.46M shares 10-Q · filed 2024-08-12 | 16.11M shares derived: average of 3 quarters · filed 2024-08-12 | 13.69M shares derived: average of 4 quarters · filed 2024-08-12 | |||
| 2023-03-31 | 16.90M shares 10-Q · filed 2024-05-15 | 15.16M shares derived: average of 2 quarters · filed 2024-05-15 | 12.25M shares derived: average of 3 quarters · filed 2024-05-15 | 10.64M shares derived: average of 4 quarters · filed 2024-05-15 | |||
| 2022-12-31 | 13.42M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-18 | 9.92M shares derived: average of 2 quarters · filed 2024-03-18 | 8.55M shares derived: average of 3 quarters · filed 2024-03-18 | 7.86M shares 10-K · filed 2024-03-18 | |||
| 2022-09-30 | 6.42M shares 10-Q · filed 2023-11-13 | 6.11M shares derived: average of 2 quarters · filed 2023-11-13 | 6.01M shares 10-Q · filed 2023-11-13 | ||||
| 2022-06-30 | 5.81M shares 10-Q · filed 2023-08-08 | 5.80M shares 10-Q · filed 2023-08-08 | |||||
| 2014-12-31 | 6.20M shares derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-31 | 3.37M shares derived: average of 2 quarters · filed 2015-03-31 | 10.97M shares derived: average of 3 quarters · filed 2015-03-31 | 1.94M shares 10-K · filed 2015-03-31 | |||
| 2014-09-30 | 532.26K shares 10-Q · filed 2014-11-14 | 13.36M shares derived: average of 2 quarters · filed 2014-11-14 | 524.60K shares 10-Q · filed 2014-11-14 | 13.28M shares derived: average of 4 quarters · filed 2015-03-31 | |||
| 2014-06-30 | 26.19M shares 10-Q · filed 2014-08-14 | 26.03M shares 10-Q · filed 2014-08-14 | 17.53M shares derived: average of 3 quarters · filed 2015-03-31 | 13.27M shares derived: average of 4 quarters · filed 2015-03-31 | |||
| 2014-03-31 | 25.88M shares 10-Q · filed 2014-05-12 | 13.20M shares derived: average of 2 quarters · filed 2015-03-31 | 8.97M shares derived: average of 3 quarters · filed 2015-03-31 | 13.09M shares derived: average of 4 quarters · filed 2015-03-31 | |||
| 2013-12-31 | 516.49K shares derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-31 | 512.57K shares derived: average of 2 quarters · filed 2015-03-31 | 8.83M shares derived: average of 3 quarters · filed 2015-03-31 | 509.47K shares 10-K · filed 2015-03-31 | 25.47M shares 10-K · filed 2014-03-26 | ||
| 2013-09-30 | 508.65K shares 10-Q · filed 2014-11-14 | 25.43M shares 10-Q · filed 2013-11-14 | 12.99M shares derived: average of 2 quarters · filed 2014-11-14 | 507.13K shares 10-Q · filed 2014-11-14 | 25.36M shares 10-Q · filed 2013-11-14 | 18.86M shares derived: average of 4 quarters · filed 2014-11-14 | |
| 2013-06-30 | 25.47M shares 10-Q · filed 2014-08-14 | 25.31M shares 10-Q · filed 2014-08-14 | 24.98M shares derived: average of 3 quarters · filed 2014-08-14 | 24.78M shares derived: average of 4 quarters · filed 2014-08-14 | |||
| 2013-03-31 | 25.16M shares 10-Q · filed 2014-05-12 | 24.73M shares derived: average of 2 quarters · filed 2014-05-12 | 24.55M shares derived: average of 3 quarters · filed 2014-05-12 | 24.45M shares derived: average of 4 quarters · filed 2014-05-12 | |||
| 2012-12-31 | 24.31M shares derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-26 | 24.24M shares derived: average of 2 quarters · filed 2014-03-26 | 24.21M shares derived: average of 3 quarters · filed 2014-03-26 | 24.18M shares 10-K · filed 2014-03-26 | |||
| 2012-09-30 | 24.17M shares 10-Q · filed 2013-11-14 | 24.17M shares derived: average of 2 quarters · filed 2013-11-14 | 24.14M shares 10-Q · filed 2013-11-14 | ||||
| 2012-06-30 | 24.16M shares 10-Q · filed 2013-08-14 | 24.12M shares 10-Q · filed 2013-08-14 | |||||
| 2012-03-31 | 24.15M shares 10-Q · filed 2013-05-15 | ||||||
| 2011-06-30 | 19.39M shares 10-Q · filed 2011-08-15 | 19.32M shares 10-Q · filed 2011-08-15 | |||||
| 2011-03-31 | 19.24M shares 10-Q · filed 2012-05-15 | ||||||
| 2010-06-30 | 27.94M shares 10-Q · filed 2011-08-15 | 27.82M shares 10-Q · filed 2011-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |